PharVision Advisers’s Guess Inc GES Stock Holding History

PharVision Advisers’s Portfolio GES Stock Details GES Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-14,043	Closed	-$197K	–	364
2024 Q4	$197K	Buy	+14,043	New	+$239K	0.17%	312

Other funds holding GES

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

PharVision Advisers's GES Position: Q1 2025 in Review

PharVision Advisers sold out of Guess Inc (GES) in Q1 2025, closing a stake of 14,043 shares — an estimated $197K sold.

PharVision Advisers first reported a position in GES in Q4 2024 and held it in 1 quarter. The position peaked at $197K in Q4 2024. 183 funds tracked by Wall St. Rank hold GES as of Q1 2025.

PharVision Advisers reported no remaining Guess Inc position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 14,043 Guess Inc shares in Q1 2025, an estimated $197K.
PharVision Advisers first reported a position in Guess Inc in Q4 2024 and held it in 1 quarter.
PharVision Advisers's Guess Inc position peaked at $197K in Q4 2024.
183 funds tracked by Wall St. Rank held Guess Inc as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.